Advanced respiratory Technologies (ART) , a pioneering spinout of Carnegie Mellon University, is developing a compact ambulatory artificial lung platform designed to help patients in respiratory failure off a ventilator so they stay awake, mobile and out of a hospital ICU. The platform works alongside a patient’s own lungs, allowing them to heal.

Expora, Inc. spinout of the University of Maryland, had a breakthrough platform for manufacturing bacterial extracellular vesicles (BEVs), nano-sized particles naturally produced by probiotics with vast potential applications in human health and disease, especially in gastrointestinal disease and gut health.

Netramind Innovations, a dynamic spinout from the University of Pittsburgh, is doing exactly that. Advancing the frontiers of disease detection through the synergy of artificial intelligence, routine eye scans, and clinical insight to save, predict and restore eyesight.

Aneurisk reflects what our region does best: connect world-class research to real-world care. It’s a team committed to improving outcomes for patients who deserve more than one-size-fits-all rules and to equipping clinicians with tools that match the complexity of aneurysm disease.